The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -2.69%. However, over the past six months, we’ve seen a weaker performance of 58.71%. The price of ALXO fallen by 28.23% over the last 30 days. And in the last five days, it has surged by 17.42%.
The stock market performance of Alx Oncology Holdings Inc has been very steady. Over the last year, the company’s stock hit its highest at $17.42 on 02/15/24, while the lowest price during the same time frame was $3.94, recorded on 08/31/23.
52-week price history of ALXO Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Alx Oncology Holdings Inc’s current trading price is -16.82% away from its 52-week high, while its distance from the 52-week low is 268.17%. The stock’s price range for this period has been between $3.94 and $17.42. The Healthcare sector company’s shares saw a trading volume of about 1.55 million for the day, which was higher than the average daily volume of 0.4 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Alx Oncology Holdings Inc (ALXO) has experienced a quarterly rise of 3.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 726.67M and boasts a workforce of 72 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 13.13, with a change in price of +4.69. Similarly, Alx Oncology Holdings Inc recorded 478,514 in trading volume during the last 100 days, posting a change of +47.86%.
ALXO’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for ALXO stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.08.
ALXO Stock Stochastic Average
As of today, the raw stochastic average of Alx Oncology Holdings Inc over the past 50 days is 57.72%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 97.21%. Additionally, the Stochastic %K and %D values for the company were 83.54% and 80.89%, respectively, over the past 20 days.
